News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|February 24, 2025

Positioning Biosimilars in Clinical Practice

Author(s)Ryan Haumschild, PharmD, MS, MBA, CPEL, Casey Butrus, PharmD

Panelists discuss how biosimilars are gaining traction through targeted education, cost-effectiveness analysis, and rigorous clinical validation, with providers increasingly integrating these alternatives by addressing knowledge barriers and demonstrating comparable therapeutic performance.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Clinical Value of Biosimilars and the Role of Interchangeability

2 experts in this video

EP. 2 The Economic Impact of Biosimilars

2 experts in this video

EP. 3 Best Practices for Employers to Maximize Uptake of Biosimilars

2 experts in this video

EP. 4 The Role of Private Label Agreements in Enhancing Access to Biosimilars

2 experts in this video

EP. 5 Key Structural and Operational Considerations for Biosimilar Adoption

2 experts in this video

EP. 6 Positioning Biosimilars in Clinical Practice

2 experts in this video

EP. 7 Assessing Patient Confidence With Biosimilars

2 experts in this video

EP. 8 The Role of Different Stakeholders in Optimizing the Uptake of Biosimilars

2 experts in this video

EP. 9 The Growing Market for Biosimilars

2 experts in this video

EP. 10 Biosimilar Pricing Strategies: Understanding High-WAC and Low-WAC Models

2 experts in this video

EP. 11 The Biosimilar Shift: How PBMs Are Reshaping Formularies

2 experts in this video

EP. 12 The Road to Biosimilar Adoption: Navigating Interchangeability

2 experts in this video

EP. 13 How the IRA is Reshaping Biosimilar Adoption

2 experts in this video

EP. 14 Cost Savings Potential Associated With the Use of Biosimilars

2 experts in this video

EP. 15 Examining the Role of Interchangeability in Clinical Practice

2 experts in this video

EP. 16 Optimizing the Implementation of Biosimilars Into Formularies

2 experts in this video

EP. 17 Key Pearls for Collaborating With Manufacturers for Successful Uptake of Biosimilars

2 experts in this video

EP. 18 Working With Policy Makers to Effectively Implement Biosimilars

Video content above is prompted by the following:

How are providers positioning biosimilars in their treatment algorithms? What can be done to increase provider confidence in biosimilars?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Ochsner Medical Center exterior | Image: Ochsner

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

August 21st 2026

Complementary, Not Competing: How an Endocrinologist Compares Dual Incretin Approaches for Obesity and MASH

ByJaime Almandoz, MD, MBA

August 21st 2026

From Siloed to Synchronized: Building the Multidisciplinary Care Model That MASH Patients Need

ByJaime Almandoz, MD, MBA

August 21st 2026

2 experts are featured in this video

Quantitative HBsAg Testing and the Path to Finite-Duration Therapy

ByRaymond Chung, MD,Douglas Dieterich, MD

August 20th 2026

2 experts are featured in this video

Monitoring Disease Progression and Liver Cancer Risk in Hepatitis B

ByRaymond Chung, MD,Douglas Dieterich, MD

August 20th 2026

Trending on AJMC

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

5 Things to Know About the FDA's Peptide Reversal

Contributor: The Deadly Gap in the Charity Care System

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Long COVID's Respiratory Overlap Explained: Marc A. Sala, MD